Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ07
- Pharmacological subgroupJ07B
- Chemical subgroupJ07BH
- Chemical substanceJ07BH01Rota virus, live attenuated
Where it is registered
Each register with its number of medicines and a few of them.
Romania
MS · 3 medicines · Historical list
European Union
EMA · 1 medicine · Historical list
All medicines with Vaccin rotavirus
Every register, a page at a time. Strengths and packs are on each medicine’s page.
21 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Rotarix | United States | 106.0CCID50 | Suspension | Marketed | GlaxoSmithKline Biologicals |
| Rotateq | United States | 2.2X10E6 IU | Suspension | Marketed | Merck Sharp & Dohme LLC |
| Rotateq | United States | 2.2X10E6 IU | Suspension | Marketed | Merck Sharp & Dohme LLC |
| RotateqCombination | Canada | 2210000 UNIT / 2 ML + 2840000 UNIT / 2 ML + 2220000 UNIT / 2 ML + 2040000 UNIT / 2 ML + 2290000 UNIT / 2 ML | Solution | Marketed | Merck Canada INC |
| Rotarix | United States | 1ML | For Suspension | Not marketed | GlaxoSmithKline Biologicals |
| Rotarix | United States | 106.0CCID50 | Suspension | Not marketed | GlaxoSmithKline Biologicals |
| Rotashield | European Union | Withdrawn | Wyeth Lederle Vaccines S.A. | ||
| Rotarix | Romania | susp. orala | Status unknown | Glaxo Smithkline Biologicals SA | |
| Rotarix | Romania | susp. orala | Status unknown | Glaxo Smithkline Biologicals SA | |
| Rotateq | Romania | sol. orala | Status unknown | MSD Vaccins | |
| Rotarix | European Union | Authorised | GlaxoSmithKline Biologicals S.A. | ||
| RotaTeq | European Union | Authorised | Merck Sharp & Dohme B.V. | ||
| Rotarix | Italy | Sospensione orale | Authorised | Glaxosmithkline Biologicals S.A. | |
| Rotateq | Italy | Soluzione orale | Authorised | Merck Sharp & Dohme B.V. | |
| Rotateq Solucion OralCombination | Spain | 2,8 U + 2,2 U + 2,2 U + 2 U + 2,3 U | solución oral | Marketed | Msd Vaccins |
| Rotateq Solucion OralCombination | Spain | 2,8x10e6 UI + 2,2x10e6 UI + 2,2x10e6 UI + 2x10e6 UI + 2,3x10e6 UI | solución oral | Marketed | Msd Vaccins |
| Rotarix | Canada | 1000000 CCID50 / 1.5 ML | Suspension | Marketed | Glaxosmithkline INC |
| Rotarix | New Zealand | Oral susp live attenuated human rotavirus 1,000,000 CCID50 per dose, prefilled oral applicator | Funded | ||
| Rotarix | New Zealand | Oral susp live attenuated human rotavirus 1,000,000 CCID50 per dose, squeezable tube (PVC free) | Funded | ||
| Rotarix Oral VaccineCombination | Saudi Arabia | Authorised | Glaxosmithkline (GSK) | ||
| Rotarix Oral Suspension VaccineCombination | Saudi Arabia | Authorised | Glaxosmithkline (GSK) |